Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-3-030-38077-9_182

PubMed Identifier: 35875174

Publication URI: http://europepmc.org/abstract/MED/35875174

Type: Journal Article/Review

Volume: 12

Parent Publication: 3 Biotech

Issue: 9

ISSN: 2190-5738